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We describe the extraction and stabilization in vitro of discrete complexes of interferon and cellular 
receptor proteins. A homogeneous complex of M, 230000 was extracted at the time of peak receptor 
binding (30 min). Complex formation was specific for human interferon. At later times a second complex 
could also be extracted suggesting transfer of interferon to a second site. 
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1. INTRODUCTION 
Interferon (IFN) binds to cells to elicit a variety 
of effects that differ both with respect to kinetics 
and to the response upon dose [l-5]. Membrane- 
binding sites have been demonstrated with 
radiolabelled IFNs [9-l l] and different forms of 
human IFN have been shown to compete for a 
common binding site [6-81. However, differences 
in binding measured at 4°C and 37’C suggest hat 
more than one site is active at the higher 
temperature [lO,ll]. To distinguish between dif- 
ferent sites and to elucidate the steps following bin- 
ding of IFN to receptor we have extracted and 
separated the cellular complexes appearing after 
the addition of IFN using lZ51-IFN as a marker. 
characteristics of labelled IFNa2 were identical 
with those of unlabelled IFIG as determined by 
competition [ 131. 
2.2. Chromatography of digitonin extracts 
2. MATERIALS AND METHODS 
2.1. Cell-bound radioactivity 
IFNa2 was labelled to a slight molar excess of 
12’1 to IFN (150&i/mg IFN protein, Mr 20000) 
[l] and added to exponentially growing Daudi cells 
at 200000 cells/ml to a final IFN concentration of 
300 units/ml. After incubation for various times at 
37”C, 4 ml culture was placed on ice, centrifuged, 
and washed twice with medium (RPM1 1640) + 1 Vo 
fetal calf serum, all at 4°C. Cells were counted for 
radioactivity (LKB-rackgamma, 80% counting ef- 
ficiency) and for cell number. The binding 
Daudi cells (IO’) were incubated with IFN as in 
section 2.1. The culture was harvested after 30 min 
treatment; 0.5 ml 1% digitonin (Calbiochem) in 
0.1 M Tris-HCl (pH 7.4) containing 1 mM 
phenylmethylsulphonyl f uoride, was added to the 
washed cell pellet. After 25 min at 2YC, the 
suspension was centrifuged for 15 min at 1100 
rev./min in an Eppendorf microfuge. The super- 
natant, containing 70% of the original cell boumd 
radioactivity was applied to a column of Sephacryl 
S-400 (Pharmacia Ltd; 1.6 x 50 cm; flow 
13 ml/h), equilibrated with 0.05% digitonin in dhe 
same Tris buffer. 0.9 ml fractions were counted 
for radioactivity. The following Mr markers (Phar- 
macia Ltd) were pre-equilibrated with digitonin 
and used to calibrate the column: aldolake, 
158000; catalase, 232000; ferritin, 4400@; 
thyroglobulin, 669000. K,, is the fractional elution 
volume for the markers. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the kinetics of binding of labelled 
IFNQ to exponentially growing Daudi cells. At 300 
units/ml, IFN will completely inhibit the growth of 
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Fig.1. Cell bound radioactivity at times after the 
addition of ‘2%IFN~2. 
these cells after one generation (-20 h). On the 
basis that peak binding represents he first reaction 
of IFN with a cellular binding site, we extracted the 
complex formed after 30 min incubation. Fig.2 
shows the gel filtration of radioactivity, solubilized 
by treatment of the cell pellet with 1% digitonin. 
Fig.2. {A) ~omato~aphy of digitonin extracts of 
Daudi cells treated with ‘2’I-WNruz: (*---+) ‘2SI-IFN~~ 
alone in digitonin; (o--e) digitonin extracts of IFN- 
treated cells. (B) Standards for molecular ratio 
estimation of the solubilized complex; (+--- ) lu,, for 
the labeiled complex extracted from Daudi cells. 
Two homogeneous peaks of radioactivity were 
separated. One corresponds to free IFN (M; 
20000); the other to a complex of Mr 230000. A 
similar separation was seen when the isolates were 
applied to sucrose density gradient (S-2Oqo in 
0.1 M Tris-HCl (pH 7.4)) and centrifuged for 
20 h (Beckman SW-41, 40000 rev./min). 
IFN accounts for >95% of the total cell-bound 
radioactivity (as estimated by binding in the 
presence of a 200-foid excess of unlabelled IFN). 
In all cases, the amounts of radioactivity found in 
the isolated complexes far exceeded the 
background amounts of non-specifically bound 
ra~oa~~vity. Identical complexes could be 
isolated from other Iymphobiastoid cells using 
both r2’1-IFNcu from Namalwa cells [ll], as we11 as 
the cloned IFNaz described here [ 121. 
The free IFN represents, for the most part, IFN 
liberated uring extraction rather than IFN which 
dissociated from the complex after extraction; 
e.g., rapid separations on small gel filtration col- 
umns that retain IFN but exclude the complex 
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Fig.3. Dissociation of “‘I-IFNcuz from the extracted 
digitonin complex after addition of an excess of 
unlabeiled IFNw. Extraction of the complex was as in 
fig.1 and 2, Labelkd extract (0.5 ml) was incubated 
overnight at 2J°C either with (o---o) or without 
(*----+) lo/cl unlabelled IFNuz containing 200000 units. 
Complexes were separated on Sephacryl S-200 
(Pharmacia Ltd.; 1.6 x 30 cm, flow 13 ml/h) in 0.05~0 
digitonin in 0.1 M Tris-HCl (pH 7.4). 
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(G-75, Pharmacia Ltd.), show a similar proportion 
of free to complexed IFN as do the slower separa- 
tions in fig.2 and 3. 
Fig.3 shows the in vitro displacement of com- 
plexed ‘251-IFNa2 following overnight incubation 
at 4”C, with an excess of unlabelled IFN. In a 
similar experiment, incubation with large amounts 
of unlabelIed mouse IFN showed no displacement. 
Attempts to reverse the displacement by incubating 
an unlabelled complex with labelled IFN, were not 
successful; nor was it possible to reconstitute the 
complex in vitro, using a digitonin extract of 
Daudi cells and labelled IFN. This suggests that 
dissociation, when it occurs, is irreversible and that 
the stability of the complex is maintained by IFN 
as well as by digitonin. 
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Most of the extractions were done at room 
temperature. Differences in stability at up to 37°C 
were not remarkable. This is in striking contrast to 
what happens to cell-bound IFN at different 
temperatures. At 4”C, cell-bound IFN has a ‘half- 
life’ of ) 10 h. At 37”C, turnover is very rapid: the 
30 min peak values are displaced with a ‘half-life’ 
of 15 min [13]. We must assume therefore that the 
metabolic activity of the cell is responsible for the 
instability of the cellular IFN-receptor complexes. 
We have reasoned elsewhere, that one of the 
functions of IFN receptors is to transfer IFN to an 
activation site [ 131. Fig.4 shows the results of 
separating digitonin complexes extracted after 
90 min incubation with labelled IFN. The ‘30 min’ 
complex is seen in diminished quantity together 
with a larger complex appearing within the void 
volume of the column, and a quantity of dialyzable 
radiolabel which may represent degraded 12’1- 
IFNcu2. 
The transfer of IFN from one complex to 
another with time supports the kinetics evidence 
for sequential binding of IFN to two cellular sites 
1131. It is significant for it offers an explanation 
for the disparity of the kinetic and dose-response 
parameters een for different effects of IFN. There 
exists a group of effects, often apparent around 
10 h after the addition of IFN, easily saturable, 
with maxima l-2 days afterwards. For Daudi cells 
this includes such effects as inhibition of viral 
multiplication and of cellular growth [ 1,2]. These 
effects correlate with the amount of IFN bound at 
3 h [13]. There exist other effects of IFN that occur 
earlier, that become very rapid as the dose in- 
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Fig.4. Comparison of separated complexes extraqted 
from Daudi cells by digitonin after 30 min and 90 thin 
incubations with ‘2sI-IFN~~. All samples were passecl on 
the same column of Sephacryl S-400 (1.6 x 22 cm; flow 
13 ml/h) in 0.05% digitonin. (A) Free IFN; (B) 30 bin 
extract; (C) 90 min extract; ( -) void volume and bed 
volume of column. 
159 
Volume 156, number 1 FEBS LETTERS June 1983 
creases; e.g., augmentation of histocompatibility 
antigens [3], and in Daudi cells, enhancement of 
cyclic GMP levels [4]. There are also effects that 
show a different response upon dose in Daudi 
cells; e.g., the enhancement of expression of 
Epstein-Barr virus early antigens is not saturated 
until the dose of IPbl approaches 10000 units/ml 
[5], in contrast to the growth effects which are 
saturated at 100 units/ml. 
Published kinetic and dose-response data are 
often incomplete. Yet it is, nevertheless, clear that 
some of the effect of IFN will correlate well with 
the amount bound to receptors; i.e., with the con- 
centration of the 30 min digitonin complex 
described here; whereas other effects will correlate 
with the concentration of the second complex 
formed later [ 131. We see then a divergence of 
pathways right from the first steps of IFN binding. 
The stability of the digitonin complexes thus offers 
the means of examining the composition and ac- 
tivity of the first components in these pathways. 
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